Relationships between serum osteocalcin levels versus blood glucose, insulin resistance and markers of systemic inflammation in central Indian type 2 diabetic patients

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 12, 2013, Pages 1631-1635

  Sarkar, P D ^a   Choudhury, Anil Baran ^b  

^a MGM MEDICAL COLLEGE   (India)

^b NSCB MEDICAL COLLEGE   (India)

Author keywords

Blood glucose homeostasis; Inflammatory markers; Insulin resistance; Osteocalcin; Type 2 diabetes mellitus

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; INSULIN; INTERLEUKIN 6; OSTEOCALCIN;

ADULT; ANALYZER; ARTICLE; BLOOD SAMPLING; BODY MASS; BONE METABOLISM; CALCIUM HOMEOSTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INDIA; INFLAMMATION; INSULIN RESISTANCE; LABORATORY TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; SERUM; WAIST HIP RATIO;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INDIA; INFLAMMATION; INSULIN RESISTANCE; MALE; MIDDLE AGED; OSTEOCALCIN; WAIST-HIP RATIO;

EID: 84884341058     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. HAUSCHKA PV, LIAN JB, COLE DE, GUNDBERG CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989; 69: 990-1047.
2. PRICE PA. Gla-containing proteins of bone. Connect Tissue Res 1989; 21: 57-60.
3. LEE NK, SOWA H, HINOI E, FERRON M, AHN JD, CONFAVREUX C, DACQUIN R, MEE PJ, MCKEE MD, JUNG DY, ZHANG Z, KIM JK, MAUVAIS-JARVIS F, DUCY P, KARSENTY G. Endocrine regulation of energy metabolism by the skeleton. Cell 2007; 130: 456-469.
4. FERRON M, HINOI E, KARSENTY G, DUCY P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild type mice. Proc Natl Acad Sci USA 2008; 105: 5266-5270.
5. PITTAS AG, HARRIS SS, ELIADES M, STARK P, DAWSONHUGHES B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab 2009; 94: 827-832.
6. ZHOU M, MA X, LI H, PAN X, TANG J, GAO Y, HOU X, LU H, BAO Y, JIA W. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur J Endocrinol 2009; 161: 723-729.
7. KANAZAWA I, YAMAGUCHI T, YAMAUCHI M, YAMAMOTO M, KURIOKA S, YANO S, SUGIMOTO T. Adiponectin is associated with changes in bone markers during glycemic control in type 2 diabetes mellitus. J Clin Endocrinol Metab 2009; 94: 3031-3037.
8. HWANG YC, JEONG IK, AHN KJ, CHUNG HY. Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporosis Int 2012; 23: 1337-1342.
9. SHOELSON SE, HERRERO L, NAAZ A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007; 132: 2169-2180.
10. SHEA MK, DALLAL GE, DAWSON-HUGHES B, ORDOVAS JM, O'DONNELL CJ, GUNDBERG CM, PETERSON JW, BOOTH SL. Vitamin K, circulating cytokines, and bone mineral density in older men and women. Am J Clin Nutr 2008; 88: 356-363.
11. DING CV, UDAYAN RJ, JONES G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 2008; 93: 1952-1958.
12. RACHON D, MYSLIWSKA J, SUCHECKA-RACHON K, SEMETKOWSKA-JURKIEWICZ B, ZORENA K, ŁYSIAK-SZYDŁOWSKA W. Serum interleukin-6 levels and bone mineral density at the femoral neck in postmenopausal women with Type 1 diabetes. Diabet Med 2003; 20: 475-480.
13. KOH JM, KHANG YH, JUNG CH, BAE S, KIM DJ, CHUNG YE, KIM GS. Higher Circulating hs-CRP levels are associated with lower bone mineral density in healthy pre-and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporosis Int 2005; 16: 1263-1271.
14. KIM M, KIM H, SOHN C. Relationship between vitamin K status, bone mineral density, and hs-CRP in young Korean women. Nutr Res Pract 2010; 4: 507-514.
15. SCHETT G, KIECHL S, WEGER S, PEDERIVA A, MAYR A, PETRANGELI M, OBERHOLLENZER F, LORENZINI R, REDLICH K, AXMANN R, ZWERINA J, WILLEIT J. High-sensitivity Creactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med 2006; 166: 2495-2501.
16. WORLD HEALTH ORGANIZATION. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complication. Report of a WHO Consultation. Part I: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva. 1999.
17. MATTHEWS DR, HOSKER JP, RUDENSKI AS, NAYLOR BA, TREACHER DF, TURNER RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
18. BOTOLIN S, MCCABE LR. Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 2006; 99: 411-424.
19. VERHAEGHE J, SUIKER AM, NYOMBA BL, VISSER WJ, EINHORN TA, DEQUEKER J, BOUILLON R. Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis. Endocrinology 1989; 124: 573-582.
20. HAMADA Y, FUJII H, FUKAGAWA M. Role of oxidation stress in diabetic bone disorder. Bone 2009; 45: 535-538.
21. KHOSLA S, PETERSON JM, EGAN K, JONES JD, RIGGS BL. Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metab 1994; 79: 707-711.
22. KANIA DM, BINKLEY N, CHECOVICH M, HAVIGHURST T, SCHILLING M, ERSHLER WB. Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. J Am Geriatr Soc 1995; 43: 236-239.
23. ISHIMI Y, MIYAURA C, JIN CH, AKATSU T, ABE E, NAKAMURA Y, YAMAGUCHI A, YOSHIKI S, MATSUDA T, HIRANO T. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990; 145: 3297-3303.
24. KWAN TAT S, PADRINES M, THÉOLEYRE S, HEYMANN D, FORTUN Y. IL-6, RANKL, TNF-alfa, IL-1. Interrelation in bone resorption pathophysiology. Cytokine Growth Factor Rev 2004; 15: 49-60.
25. DE BENEDETTI F, RUCCI N, DEL FATTORE A, PERUZZI B, PARO R, LONGO M, VIVARELLI M, MURATORI F, BERNI S, BALLANTI P, FERRARI S, TETI A. Impaired skeletal development in interleukin-6 transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum 2006; 54: 3551-3563.
26. HAMANN C, GOETTSCH C, METTELSIEFEN J, HENKENJOHANN V, RAUNER M, HEMPEL U, BERNHARDT R, FRATZLZELMAN N, ROSCHGER P, RAMMELT S, GUNTHER KP, HOFBAUER L-C. Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function. Am J Physiol Endocrinol Metab 2011; 301: E1220-1228.